Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Federico De Stefano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0063-0307; OpenAlex author ID A5048766679. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2023: 2 papers · 2024: 2 papers · 2025: 2 papers · 2026: 7 papers

Papers 13

  1. Neoadjuvant Chemotherapy With or Without Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamasurg.2026.3716↗
  2. Pancreatic cancer surgery in Italy: an updated snapshot from a national multicentre analysis of outcomes by hospital volume. Co-author DOI 10.1007/s13304-026-02813-5↗
  3. Driving tumor-associated macrophages to a CXCL9Hi/SPP1Low phenotype eliminates pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2026.102938↗
  4. Actual Five-year Survival After Neoadjuvant Therapy and Resection for Localized Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000007214↗
  5. Risk Factors for Early Disease-Related Mortality Among Patients with Localized Pancreatic Cancer Resected After Neoadjuvant Treatment. Co-author DOI 10.1245/s10434-026-19218-8↗
  6. ASO Visual Abstract: Risk Factors for Early Disease-Related Mortality Among Patients with Localized Pancreatic Cancer Resected After Neoadjuvant Treatment. Co-author DOI 10.1245/s10434-026-19370-1↗
  7. ASO Author Reflections: Early Disease-Related Mortality After Neoadjuvant Therapy and Radical Resection for Pancreatic Ductal Adenocarcinoma-The Biological Bur… Co-author DOI 10.1245/s10434-026-19400-y↗
  8. Reducing the burden of pancreatic cancer by surveilling mucinous cystic neoplasms: are we there yet? Co-author DOI 10.1016/j.bpg.2025.101998↗
  9. Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological a… First author DOI 10.1093/bjsopen/zraf033↗
  10. Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence. Co-author DOI 10.1016/j.surg.2024.07.026↗
  11. Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biological R2 Definition". Co-author DOI 10.1245/s10434-024-15105-2↗
  12. Surgical Planning for "Borderline Resectable" and "Locally Advanced" Pancreatic Cancer During Open Pancreatic Resection. First author DOI 10.1007/s11605-023-05848-w↗
  13. Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence. Co-author DOI 10.1016/j.ejso.2023.03.229↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stefano Crippa · 11 shared papers, 2023–2026 · strength 2.65
  2. Giulio Belfiori · 10 shared papers, 2023–2026 · strength 2.28
  3. Massimo Falconi · 10 shared papers, 2023–2026 · strength 2.28
  4. Stefano Partelli · 9 shared papers, 2023–2026 · strength 1.85
  5. Domenico Tamburrino · 9 shared papers, 2023–2026 · strength 1.85
  6. Marco Schiavo Lena · 7 shared papers, 2024–2026 · strength 1.47
  7. Michele Reni · 6 shared papers, 2024–2026 · strength 1.27
  8. Nicolò Pecorelli · 6 shared papers, 2023–2026 · strength 1.22
  9. Giulia Gasparini · 6 shared papers, 2023–2026 · strength 1.22
  10. Diego Palumbo · 5 shared papers, 2024–2026 · strength 1.05
  11. Francesco DE COBELLI · 4 shared papers, 2025–2026 · strength 0.87
  12. Paolo Riccardo Camisa · 4 shared papers, 2024–2026 · strength 0.85
  13. Giuseppe Malleo · 2 shared papers, 2026 · strength 0.46
  14. Fabio Casciani · 2 shared papers, 2026 · strength 0.46
  15. Gabriella Lionetto Lionetto · 2 shared papers, 2026 · strength 0.46
  16. Claudio Luchini · 2 shared papers, 2026 · strength 0.46
  17. Roberto Salvia · 2 shared papers, 2026 · strength 0.46
  18. Theodore Sunki Hong · 2 shared papers, 2026 · strength 0.42
  19. Carlos Fernández-del Castillo · 2 shared papers, 2026 · strength 0.42
  20. David P. Ryan · 2 shared papers, 2026 · strength 0.42
  21. Motaz Qadan · 2 shared papers, 2026 · strength 0.42
  22. Jennifer Yon-Li Wo · 2 shared papers, 2026 · strength 0.42
  23. Keith D. Lillemoe · 2 shared papers, 2026 · strength 0.42
  24. Colin D. Weekes · 2 shared papers, 2026 · strength 0.42
  25. Giovanni Marchegiani · 1 shared paper, 2025 · strength 0.37

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.